Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4116 |  OABIW OmniAb, Inc. - Warrant | 0.3900 USD | 0.00% | 0.00% | +6.12% | +160.00% | 56.70 M USD | ||
| 4119 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.00 USD | -3.68% | -12.35% | -13.32% | 0.00% | 56.13 M USD | ||
| 4120 |  GUTS Fractyl Health, Inc. - Common Stock | 4.23 USD | -6.42% | +861.36% | +531.34% | +200.00% | 56.11 M USD | ||
| 4125 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.07 USD | -7.53% | -9.44% | -31.17% | -27.59% | 55.65 M USD | ||
| 4126 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.88 USD | -6.38% | -10.20% | -55.78% | -56.00% | 55.42 M USD | ||
| 4139 |  LONA LeonaBio, Inc. - Common Stock | 5.75 USD | -1.37% | +32.49% | -19.47% | -14.69% | 54.17 M USD | ||
| 4141 |  ACET Adicet Bio, Inc. - Common Stock | 5.74 USD | -7.12% | -14.33% | -39.32% | +523.91% | 53.73 M USD | ||
| 4151 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.37 USD | -6.13% | -12.69% | -4.80% | -62.47% | 52.37 M USD | ||
| 4155 |  DOMH Dominari Holdings Inc. - Common Stock | 2.15 USD | -0.46% | +2.38% | +11.40% | -65.82% | 52.12 M USD | ||
| 4156 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | 0.00% | +1.35% | +0.67% | +947.67% | 52.10 M USD | ||
| 4161 |  CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 USD | -22.58% | -61.29% | -66.20% | -82.61% | 51.46 M USD | ||
| 4168 |  SER Serina Therapeutics, Inc. Common Stock | 2.00 USD | -0.99% | +0.50% | -20.00% | +19.76% | 50.80 M USD | ||
| 4169 |  INMB INmune Bio Inc. - Common stock | 1.83 USD | -1.61% | -5.67% | -24.69% | -7.58% | 50.79 M USD | ||
| 4172 |  ANVS Annovis Bio, Inc. Common Stock | 1.18 USD | -1.67% | -0.84% | -2.48% | -27.16% | 50.28 M USD | ||
| 4178 |  CRVO CervoMed Inc. - Common Stock | 3.28 USD | +3.14% | +10.81% | +31.20% | -61.82% | 49.59 M USD | ||
| 4194 |  APLM Apollomics Inc. - Class A Ordinary Shares | 21.70 USD | +0.93% | -7.66% | -9.21% | +17.93% | 47.65 M USD | ||
| 4196 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 1.81 USD | -2.16% | -7.65% | -16.59% | -81.90% | 47.57 M USD | ||
| 4199 |  CELU Celularity Inc. - Class A Common Stock | 1.46 USD | -0.68% | +2.10% | +1.39% | -32.09% | 47.38 M USD | ||
| 4203 |  IMA ImageneBio, Inc. - Common Stock | 4.12 USD | -10.63% | -10.04% | -17.93% | -49.39% | 46.77 M USD | ||
| 4211 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.06 USD | +8.78% | +7.13% | -2.75% | +854.05% | 45.97 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |